| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 88254-07-3 | 5,12-Naphthacenedione, 10-3-(3-cyano-4-morpholinyl)-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyloxy-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-; 5,12-Naphthacenedione, 10-3-(3-cyano-4-morpholinyl)-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyloxy-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-; 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin; (8S)-1-Methoxy-6,8α,11-trihydroxy-8β-(hydroxyacetyl)-10α-[[3-(3-cyanomorpholino)-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-5,12-naphthacenedione; (8S,10S)-10α-[[3-(3-Cyano-4-morpholinyl)-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8α,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione; 3'-Deamino-3'-(3-cyano-4-morpholinyl)adriamycin; Cyanomorpholinodoxorubicin; MRA CN; MRA-CN | 无 | 详情 | 供应商 |
sitemap.xml